Featured Story | By Nick Paul Taylor GlaxoSmithKline has struck a deal to buy Sierra Oncology for $1.9 billion for a near-approval cancer drug, completing a remarkable turnaround for the biotech and the Gilead castoff it bet its future on. read more |
| |
|---|
|
Top Stories By Max Bayer The Bristol Myers Squibb Foundation is expanding its two initiatives aimed at bolstering diversity among clinical trial investigators, adding Gilead as a sponsor. read more By Nick Paul Taylor Boehringer Ingelheim has come sweeping down into Oklahoma to land rights to a treatment for the most common type of permanent hearing loss, joining up with Autigen in a $100 million biobuck deal to work on a drug that restores sensory hair cells. read more By Max Bayer Swiss biotech CDR Life has nabbed $76 million in series A bucks to flesh out its multispecific T-cell engagers, a fundraising haul led by Sanofi-backed, Paris investment firm Jeito Capital, which now turns its attention toward bolstering autoimmune programs. read more By Max Bayer Ophthalmology-focused ProQR is axing 30% of its workforce, including its chief scientific officer, and re-strategizing, more than two months after its most developed asset, sepofarsen, failed to improve vision in kids with congenital eye disease in a phase 2/3 trial. read more By Gabrielle Masson Cardiff Oncology’s chief medical officer, Katherine Ruffner, M.D., will be departing the cancer-focused biotech after just 10 months. Ruffner is leaving the clinical-stage biotech—which received funding from Pfizer last year to develop its PLK1 inhibitor onvansertib—on April 22 “to pursue a new opportunity." read more By Gabrielle Masson Novel cell therapy company Cimeio Therapeutics is exiting stealth mode—though its science isn’t. The Versant Ventures-backed company has publicly entered the industry with a $50 million series A financing round. read more By Kevin Dunleavy Is the FDA tightening its screws on drug application approvals? Analysts at Evercore ISI note that of the 14 cases they’ve found where companies have reported receiving a "deficiency" notice, more than half have come within the last year. read more By Conor Hale According to the agency, some healthcare providers may not be using these AI aids as intended when evaluating potential large-vessel occlusions. read more By Robert King New bipartisan legislation aims to dole out $250 million to behavioral health providers to adopt electronic health records and other health IT systems. read more By Angus Liu Halozyme is best known for its under-the-skin drug delivery platform, with partnerships with the likes of Johnson & Johnson, GlaxoSmithKline and Roche. The company is now buying into the auto-injector realm and setting out to cultivate an internal commercial team. read more By Andrea Park With the commercial rollout of its first prescription digital therapeutic for ADHD well underway, Akili Interactive is now turning its attention to other conditions that its particular brand of video game-based treatments could potentially address. read more Resources Sponsored by: Nethealth Net Health, experts in wound care and dermatology clinical trials, have a new eBook: 5 Rules to Enhance Clinical Trials in 2022, find out how to recruit the right participants, connect patients and researchers with technology, manage costs and more. Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Presented By: Springer Nature The journey of drug development in 2021 delivered to your inbox: top 10 AdisInsight drug profiles viewed, new drug profiles released, overview of drug launches, key deals, research trends in 2021 and much more (free of charge). Sponsored by: Blue Matter, strategic consultants in the life sciences What’s in store for the oncology market in 2022 and beyond? This paper looks at 5 trends driving the market. Sponsored by: Thermo Fisher Scientific Learn how to position quality as a central component within your raw material sourcing strategies for the chemicals used throughout your workflows. Download the free whitepaper from Thermo Fisher Scientific. Sponsored by: Thermo Fisher Scientific Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow. Sponsored by: Oracle Health Sciences Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research. Cancer Progress 2022: Hear from Leading Oncology Innovators May 10-12, 2022 | Virtual Fierce Promotional Review Committee Compliance and Best Practices Summit April 12-14, 2022 | New Brunswick, NJ Accelerating Immuno-Oncology and Oncology Drug Development Using Humanized Mice Live & Recorded on: Thursday, April 21, 2022 | 12pm ET / 9am PT Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Virtual Event Promotional Review Committee Compliance and Best Practices Summit West (PRC West) September 2022 | San Diego, CA Fierce New Product Planning Summit September 20-22, 2022 | Boston, MA Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Pharma Marketing Awards October 19, 2022 | Philadelphia, PA Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Fierce European Trial Master File Summit November 14-16, 2022 | London, UK Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Virtual Event Fierce JPM Week 2023 January 2023 | San Francisco, CA & Virtual | 
